Dexmethsone

Riik: Uus-Meremaa

keel: inglise

Allikas: Medsafe (Medicines Safety Authority)

Osta kohe

Toimeaine:

Dexamethasone sodium phosphate 4.4mg equivalent to dexamethasone phosphate 4.0 mg

Saadav alates:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (Rahvusvaheline Nimetus):

Dexamethasone sodium phosphate 4.4 mg (equivalent to dexamethasone phosphate 4.0 mg)

Annus:

4 mg/mL

Ravimvorm:

Solution for injection

Koostis:

Active: Dexamethasone sodium phosphate 4.4mg equivalent to dexamethasone phosphate 4.0 mg Excipient: Creatinine Sodium citrate Water for injection

Retsepti tüüp:

Prescription

Valmistatud:

Sanofi Chimie

Näidustused:

Replacement Therapy Adrenocortical Insufficiency Dexamethasone has predominantly glucocorticoid activity and, therefore, is not a complete replacement therapy in cases of adrenocortical insufficiency. Dexamethasone should be supplemented with salt and/or a mineralocorticoid, such as deoxycorticosterone. When so supplemented, dexamethasone is indicated in the following: · Acute adrenocortical insufficiency · Addison's disease · Bilateral adrenalectomy · Relative adrenocortical insufficiency · Primary and secondary adrenocortical insufficiency Prolonged administration of adrenocortical steroids can produce dormancy of the adrenal cortex. The reduced secretory capacity gives rise to a state of relative adrenocortical insufficiency which persists for a varying length of time after therapy is discontinued. Should a patient be subjected to a sudden stress during this period of reduced secretion (for up to two years after therapy has ceased) the steroid output may not be adequate. Steroid therapy should, therefore, be reinstituted to help cope with stress such as that associated with surgery, trauma, burns or severe infections where specific antibiotic therapy is available.

Toote kokkuvõte:

Package - Contents - Shelf Life: Vial, glass, single dose, 5 x 1 ml type I, amber vial with grey chlorobutyl stopper - 5 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 5 x 2 ml type I, amber vial with grey chlorobutyl stopper - 10 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 10 x 1 ml type I, amber vial with grey chlorobutyl stopper - 10 mL - 12 months from date of manufacture stored at or below 25°C protect from light - Vial, glass, single dose, 10 x 2 ml type I, amber vial with grey chlorobutyl stopper - 20 mL - 12 months from date of manufacture stored at or below 25°C protect from light

Loa andmise kuupäev:

2013-04-02

Vaadake dokumentide ajalugu